USA:  BLEVF  |  Canada:  BE  |  Germany: 4B9
Website  |  SEC Filings  |  Latest News

There’s a storm on the horizon – and no, it has nothing to do with the weather!

Canada is just a mere MONTHS away from Legalizing Recreational Marijuana, as soon as this Summer, and the impact will be ENORMOUS.

THIS CAN NOT BE UNDERSTATED.  Simply put, Canada’s legalization will be the among the BIGGEST EVENTS IN THE HISTORY OF THE CANNABIS SECTOR!

This will NEVER happen again.  There will NEVER be another Banned Substance made legal on this scale – creating a future TRILLION Dollar Global Market.

And that’s why the focus must shift primarily to CANADIAN Cannabis companies who are poised to capitalize tremendously off of this ONCE-IN-A-LIFETIME Event.

“The GREEN RUSH is ON”  and this Cannabis Company is poised capture a piece of the $12 BILLION up for Grabs as Canada Legalizes Cannabis!

So there may be NO BETTER TIME than Right Now to consider BLEVF (Beleave Inc)!

Beleave Inc. (BLEVF) is a Biotech company focused on the production of Medical Marijuana in Canada.

The Company’s wholly owned subsidiary, Beleave Kannabis Corp., has received a license to cultivate medical Marijuana at its facility by Health Canada.

Unlike many others who are still “Pending”, BLEVF is a Health Canada-LICENSED company with a strong cash position, well-funded to meet the enormous demand coming from Canada’s Full Legalization this Summer!

BLEVF takes a unique and highly scientific approach to the development of Cannabis-related products, research, and therapies, utilizing it’s strong BioTech background with a capable team as it’s backbone.


BLEVF’s objective isn’t complicated.  The company aims to to further the unexplored medicinal applications of Cannabis to provide consistent, reliable and standardized products.

BLEVF’s 14,500 sq. ft. facility in Hamilton, Ontario is already on track to produce 950 kg of dried Cannabis per year (yield of 82g/sqft.; 150kg per cycle; 5 – 6 cycles a year) with projections of up $50-70 MILLION in Revenues at a 40-50% Margin!

The company is now building out a 80,000 sq. ft. hybrid Greenhouse (65000 sqft of which will be used for flowering Cannabis) that is expected to come online in Q3 and provide a projected yield of 26,000-32,000 kg of dried cannabis annually to meet coming demand!

BLEVF is also among the “Elite Few” Canadian producers to receive a License from Health Canada.

Cannabis Flower Cultivation (granted 5/2017)
Cannabis Sales License (granted 4/2018)
Oil/Extract Production (granted 12/2017)
Oil/Extract Sales License (granted 4/2018)
Dealers License (in progress)

BLEVF’s core strength is it’s Research & Development arm, in collaboration with top institutions like Ryerson University, Guelph University & The University of Toronto. 

The company has the ability to isolate compounds through new techniques using breeding, extraction and analytical equipment to develop products for Orthopedic Pain Therapies and the Edibles Market!

“As we continue to progress the science behind our craft, we’ll be able to advance therapeutical applications that will allow customized treatment options for patients. This includes symptom management strategies and the ability to allow healthcare practitioners a more comprehensive oversight of their patients’ treatment.”


Cannabis extraction is a highly complex and scientific process. The goal is to separate the beneficial compounds from the unusable plant materials.

So as cannabis extracts become more widely available for use, finding streamlined, safe and industrialized processes to properly extract cannabinoids and terpenes are becoming a focal point for many medical cannabis manufacturers.

BLEVF has developed a unique approach to cannabinoid extraction and recovery that could REVOLUTIONIZE the future of Cannabis product development and commercialization!

BLEVF’s Extraction Method allows them to extract high-purity active ingredients from Cannabis like THC and CBD which will provide a cost-effective solution and increase shelf-life for Edibles and Medicinal Therapies!Led by Dr. Lesley Campbell, an Associate Professor in Ryerson University’s, BLEVF’s current projects include a now Patent-Pending Industrialized Cannabinoid Extraction Method and a Breeding & Genetics Program.

In fact, the company is currently working on a project to incorporate these cannabinoids into sucrose and flour for the Edibles Market!

The results of the Breeding & Genetics Program have led to a new, technologically advanced means of predicting cannabinoid and terpene extraction for production from VERY YOUNG PLANTS & SEEDS!


If you’ve ever smoked a pack of cigarettes, you’ll notice that there is barely a difference, if it all, in the Tobacco from pack-to-pack. 

Like Tobacco, once Cannabis goes legal, the goal will be to produce a standardized strain that can reliably grow over and over to exact specifications and made available for market.

BLEVF’s team has created a method to identify those biomarkers in large seed banks to select the best cultivars for breeding.  This will allow them to efficiantly choose only the Highest-Producing Plants with the best strains!


Check out this video to learn more about
BLEVF’s Game-Changing Process here:


And now that BLEVF has obtained their Sales Licence, credited patients could now buy medical weed from them online and receive it in the mail!

In terms of recreational sales, the team is waiting until the official legalization of the drug set for this summer.


Well-funded and ready to ramp up for Canada’s recreational market, BLEVF recently announced a key Acquisition that could truly take them to the next level!

Beleave Inc. Acquires Medi-Green’s Network of Medical Cannabis Clinics in Ontario

Medi-Green has operated since 2015 and since then has opened 3 locations with plans to rapidly expand its footprint over the next 12 months. The company currently has an active patient base of approximately 4,000 with average patient subscriptions in the 2 to 3 gram per day range.

Average prescription sizes could yield sales of between 2,900 and 4,400 kilograms in annual sales from its initial three locations alone!

Medi-Green has no long-term debt and had annual revenue of approximately $2.9 Million in 2017.

“Integrating with clinics is a proven model which provides a significant and fluid referral program between medical practitioners and prescribing doctors,” commented Andrew Wnek , Beleave’s Chief Executive Officer.

“Our team is eager and excited to work under the Beleave brand. We feel our team aligns nicely with Beleave and their attention to quality assurance and sound science will be beneficial to our patients,” commented Trevor Hands , C.E.O. of Medi-Green.

“Together I think we can bring strong vision and expertise to multiple areas of the ACMPR market, the newly emerging recreational sector, as well as other domestic and international opportunities. We plan on adding at least six more locations by the end of 2018.”

Essentially, all these Medi-Green customers are now BLEVF Customers!



Canada’s cannabis industry is expected to surpass $22 BIL in size over the coming years, according to Deloitte, with over 140,000 registered medical marijuana patients today. The industry is expected to see a shortfall in supply with the near-term plans to legalize marijuana for recreational use.

However, the industry is expected to see a shortfall in supply with the near-term plans to legalize marijuana for recreational use.



As an Licensed Producer, BLEVF has a tremendous opportunity in this market. 

As stated earlier, the company is already capable of producing up to 950K Grams of dried Cannabis per year and with the completion of it’s 80,000 sq. ft. hybrid Greenhouse in Q3, they are projecting a yield of 26,000-32,000 kilograms of dried cannabis annually!

Needless to say, this could lead to some serious Revenues for the company and a windfall in Gains for shareholders!


BLEVF is truly in the right place at the right time.

More than any other Cannabis play we’ve seen, this company has formed a team of amazing experts and researchers and appears primed and ready to meet the coming demand that Canada’s Weed Legalization will pose.

Needless to say, the Upside here is incredible from both a financial and technical perspective!

With much to look forward to, make sure you put BLEVF on your screen RIGHT NOW!


Check it out NOW with your Broker below:


Or if you need a Broker, we recommend our partner: 

Please Read our Full Disclaimer:

This report/release/advertorial/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.  The paying party may own shares and may liquidate them during the promotional period.

PLEASE NOTE WELL: and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. WALLSTREETALERTS.ORG WILL NEVER ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED at &/OR ANY OF OUR SOCIAL NETWORKING AND EMAIL ADVERTISING PLATFORMS.

This Website & Newsletter is now owned and operated by Link Media. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our”  refers to Link Media and/or it’s subscriber base.Our website and newsletter are for Entertainment purposes only.This newsletter is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. 

We encourage all to read the SEC’s INVESTOR ALERT before reading this Newsletter.

Release of Liability: Through use of this email and/or website advertisement viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by or an offer or solicitation to buy or sell any security. 

COMPENSATION: has been compensated one-hundred and thirty-five thousand dollars cash via bank wire by Beleave Inc. for a two week advertising services contract which includes the preparation, publication, and management of this corporate profile as well as other marketing and investor relations services.. does not own any shares of BLEVF. 

All Content, Distribution, and editorial control has been given, reviewed, and approved by Beleave Inc. does not investigate the background of any third party. The third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. may purchase shares on the open market of any mentioned company following the dissemination of this email. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Further, has no advance knowledge of any future events of the profiled companies which includes, but is not limited to, news & press releases, changes in corporate structure, or changes in share structure.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. is compliant with the Can Spam Act of 2003. does not offer such advice or analysis, and further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements.  Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage. 

In preparing this publication, has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. is not responsible for any claims made by the companies advertised herein, nor is responsible for any other promotional firm, its program or its structure.